Corifact 1250 1250 Unit

CORIFACT 1250 is a powder for solution containing Factor XIII, used for managing bleeding disorders. This intravenous medication supports blood clotting and is manufactured by CSL Behring Canada Inc.

CORIFACT 1250 is primarily used to treat bleeding disorders related to Factor XIII deficiency. It works by helping blood to clot properly, which is essential for controlling bleeding episodes. This medication is often prescribed for individuals who have a genetic lack of Factor XIII, a protein crucial for blood coagulation. People may wonder, 'What is Factor XIII used for?' and the answer lies in its role in stabilizing blood clots to prevent excessive bleeding.

When administered intravenously, CORIFACT 1250 helps to stabilize blood clots, reducing the risk of bleeding episodes. Common effects may include improved clotting ability, which can be particularly beneficial for individuals with bleeding disorders. It's important to note that individual responses to the medication can vary, and not everyone will experience the same effects.

CORIFACT 1250 should be handled with care and stored as directed to maintain its effectiveness. It is crucial to follow the healthcare provider's instructions for administration and to report any unusual symptoms. Individuals with known allergies to any components of the medication should avoid its use. Always consult a healthcare professional before starting any new medication.

CORIFACT 1250 may interact with other medications, so it's important to inform your healthcare provider about all the drugs you are taking. Certain medications, such as blood thinners, may affect the way CORIFACT 1250 works. Additionally, alcohol and other substances may influence the medication's effectiveness, so it's advisable to discuss potential interactions with a healthcare professional.